top of page

Eye Rest My Case: University of Missouri Settles Litigation over Dry Eye Research

February 22, 2021


As reported by the Associated Press, the University of Missouri System and former pharmacy professor, Ashim Mitra, have reached a confidential settlement, thereby ending the University’s patent-related litigation against Mitra.

The underlying litigation alleged that Mitra had improperly sold research belonging to the University to Auven Therapeutics Management, a pharmaceutical development company based in the U.S. Virgin Islands, for $1.5 million plus ongoing royalties. Apparently, Auven later resold the work to Sun Pharmaceutical Industries for $40 million plus royalties.

The research related to the development of a more effective drug delivery method in the treatment of dry eye. According to the University, the research and patents belonged to them, as a student had developed the underlying treatment while working as a graduate research assistant at the institution.

Mitra denied these and other allegations of wrongdoing but ultimately resigned from the University’s School of Pharmacy in 2019.


Authors: Larissa Fulop and Nargis Fazli


Commenting has been turned off.
  • X
  • LinkedIn Icon (Goodmans IP)
  • Goodmans Intellectual Property Web
bottom of page